During the past decade, Cornerstone Eye Care conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 9 clinical trials were completed, i.e. on average, 90% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 7 clinical trials were completed. i.e. 233.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cornerstone Eye Care" #1 sponsor was "Allergan" with 4 trials, followed by "Bausch & Lomb Incorporated" with 3 trials sponsored, "Kala Pharmaceuticals, Inc." with 2 trials sponsored, "Merck Sharp & Dohme LLC" with 2 trials sponsored and "Santen Inc." with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

According to Clinical.Site data, the most researched conditions in "Cornerstone Eye Care" are "Dry Eye Syndromes" (3 trials), "Ocular Hypertension" (3 trials), "Keratoconjunctivitis Sicca" (2 trials), "Open-Angle Glaucoma" (2 trials) and "Bacterial Conjunctivitis" (1 trials). Many other conditions were trialed in "Cornerstone Eye Care" in a lesser frequency.

Most popular intervention types in "Cornerstone Eye Care" are "Drug" (19 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "0.005% latanoprost" (1 trials), "011516X (New Artificial Tear Formulation)" (1 trials), "AGN-195263 0.01%" (1 trials) and "AGN-195263 0.03%" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cornerstone Eye Care" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Cornerstone Eye Care". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Cornerstone Eye Care, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cornerstone Eye Care, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".